Apr 04, 2022
In the spring of 1992 faculty representatives from Mount Sinai School of Medicine and its affiliates, Oxford University, and The Graduate School, CUNY, joined to form the Oxford-Mount Sinai Consortium on Bioethics. Since then, the group has evolved. The participating institutions now include: Icahn School of Medicine at Mount Sinai, Oxford University, King's College London, the Vrije University of Amsterdam, and Bar Ilan University and the participating faculty members have become a community of scholars.
Mar 31, 2022
Amanda Merkelson, MPH, Associate Director of the BioMe Biobank Program, is proud of her team that has been instrumental in enrolling a diverse population of patients in the vital pursuit of genomic studies.
Mar 31, 2022
Partners to Provide Unique Expertise and Resources into Immune System Exposure, Patient Segmentation, and Target Identification
Jan 26, 2022
To identify individuals harboring NDD CNVs in a multiancestry biobank and to query their enrichment for select neuropsychiatric disorders as well as association with multiple medical disorders.
Jan 25, 2022
Population-based assessment of disease risk associated with gene variants informs clinical decisions and risk stratification approaches.
Oct 21, 2021
The Bruce and Cynthia Sherman Charitable Foundation has announced Judy H. Cho, MD as a recipient of the 2021 Sherman Prize, which recognizes excellence in the field of Crohn’s disease and ulcerative colitis, two forms of inflammatory bowel disease (IBD).
Jun 07, 2021
We are pleased to announce the establishment of a new Division of Data Driven and Digital Medicine within the Department of Medicine at the Icahn School of Medicine at Mount Sinai. Led by Girish N. Nadkarni, MD, the Division’s mission is to create a data science and digital health hub to catalyze translational research.
Jun 05, 2021
Forrest IS, Jaladanki SK, Paranjpe I, Glicksberg BS, Nadkarni GN, Do R.
Infection. 2021 Jun 5:1-9. doi: 10.1007/s15010-021-01633-6. Online ahead of print.
May 19, 2021
As part of our COVID-19 Long-Hauler study, this shows COVID-related symptoms weighted by the number of BioMe participants for whom those symptoms were still being discussed 90 days following COVID-19 diagnosis, when never mentioned for those participants prior to two weeks before diagnosis, so as to ignore preexisting symptoms. While we have data on 2604 Covid+ patients in BioMe, this represents 681 participants who had notes available 90 days post-diagnosis." -Tielman Van Vleck, IPM Associate Computational Scientist and BioMe Co-Investigator
Apr 01, 2021
Lili Chan & Girish N Nadkarni
#nephrology #covid19 #NadkarniLab #MountSinaiCOVIDInformaticsCenter
Mar 31, 2021
New study identifies a new approach that will help personalize treatment for patients diagnosed with Crohn’s disease. #judycho #chrohns
Mar 15, 2021
The Sanford J. Grossman Charitable Trust, founded by renowned economist and philanthropist Sanford J. Grossman, PhD, has committed $5.9 million to establish the Sanford Grossman Interdisciplinary Center in Neural Circuitry and Immune Function at the Icahn School of Medicine at Mount Sinai.
Feb 01, 2021
Soluble urokinase plasminogen activator receptor (suPAR) is the circulating form of urokinase plasminogen activator receptor, a glycosyl-phosphatidylinositol–anchored membrane protein expressed in various cell types including kidney podocytes and endothelial cells.
Jan 29, 2021
IPM researcher Professor Ruth Loos was offered the opportunity to join the NNF Center for Basic Metabolic Research and awarded seven-year DKK50 million Laureate Research Grant from the Novo Nordisk Foundation.
Jan 27, 2021
Identifying the relationships between chromosome structures, nuclear bodies, chromatin states and gene expression is an overarching goal of nuclear-organization studies.
Dec 04, 2020
BioMe called “heroes” for providing 360 de-identified plasma samples to Mount Sinai’s Department of Pathology, Molecular and Cell-based Medicine to help “define the normal level of Cytokines and anti COVID19 Antibodies required by the NYSDOH Wadsworth Center.”
Nov 23, 2020
Genetic studies of blood pressure (BP) to date have mainly analyzed common variants (minor allele frequency > 0.05).
Oct 23, 2020
Interindividual clinical variability in the course of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is vast.
Oct 19, 2020
The National Academy of Medicine (NAM) is a leading organization dedicated to promoting science, health equity, and trusted medical advice nationally and globally in order to broadly promote human health. For these reasons, I am deeply honored to have been elected to NAM. This recognition substantially reflects the impact of BioMe as a forward-looking research endeavor committed to rapidly applying research advances to improve patient health. On a personal level, I am a participant in BioMe; by volunteering, each of us can advance knowledge to improve outcomes for ourselves and others.
Jun 15, 2020
Recent study published in the JCI, the Itan lab demonstrated a good use of BioMe Biobank samples where they performed PheWAS analyses in BioMe Biobank samples to support the evidence that mutations in the gene CRY1 are associated with ADHD and insomnia
Jun 09, 2020
Polygenic risk scores (PRS) for coronary artery disease (CAD) identify high-risk individuals more likely to benefit from primary prevention statin therapy.